Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven B Shoemaker

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Annals of Thoracic Surgery|April 6, 2004
Left ventricular dysfunction after pericardiectomy for constrictive pericarditisRichard S Schofield, Steven B Shoemaker, Eugene G Ryerson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 10, 2007
Cardiac transplantation in patients with anti-phospholipid antibodiesRichard S Schofield, Juan M Aranda, Steven B Shoemaker, et al.
Clinical Cardiology|April 24, 2003
Images in cardiology: a case of giant left atriumRichard S Schofield, Steven B Shoemaker, Danel F Pauly, et al.
Thrombosis Research|November 18, 2008
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patientsDominick J Angiolillo, Piera Capranzano, Bhaloo Desai, et al.
The American Journal of Cardiology|March 4, 2008
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatmentDominick J Angiolillo, Marco A Costa, Steven B Shoemaker, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Annals of Thoracic Surgery|April 6, 2004
Left ventricular dysfunction after pericardiectomy for constrictive pericarditisRichard S Schofield, Steven B Shoemaker, Eugene G Ryerson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 10, 2007
Cardiac transplantation in patients with anti-phospholipid antibodiesRichard S Schofield, Juan M Aranda, Steven B Shoemaker, et al.
Clinical Cardiology|April 24, 2003
Images in cardiology: a case of giant left atriumRichard S Schofield, Steven B Shoemaker, Danel F Pauly, et al.
Thrombosis Research|November 18, 2008
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patientsDominick J Angiolillo, Piera Capranzano, Bhaloo Desai, et al.
The American Journal of Cardiology|March 4, 2008
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatmentDominick J Angiolillo, Marco A Costa, Steven B Shoemaker, et al.
Circulation|January 31, 2007
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyDominick J Angiolillo, Steven B Shoemaker, Bhaloo Desai, et al.
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Pageof 1